The Immunological Diagnosis of Human Malignant Disease

Caspary E. A. Field E. J. An encephalitogenic protein of human origin; some chemical and biological properties. Ann. N.Y. Acad. Sci. 122 (1965) 182.

Paterson P. Y. Experimental allergic encephalomyelitis and autoimmune disease. Adv. Immunol. 5 (1966) 131.

Field E. J. The brain and nervous system in allergic disease, in Clinical Aspects of Immunology, 3rd ed., 1545–86, ed. Gell P. G. H. Coombs R. R. A. Lachmann P. J. (1975).

Bloom B. R. In vitro methods in cell-mediated immunity in man. New Engl. J. Med. 284 (1971) 1212.

David J. R. Al-Askari S. Lawrence H. S. Thomas L. Delayed hypersensitivity in vitro. I. The specificity of inhibition of cell migration by antigens. J. Immunol. 93 (1964) 264.

Søborg M. Bendixen G. Human lymphocyte migration as a parameter of hypersensitivity. Acta med. scand. 181 (1967) 247.

Bloom B. R. Bennett B. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 153 (1966) 80.

Coulson A. S. Chalmers D. G. Response of human blood lymphocytes to tuberculin PPD in tissue cultures. Immunology 12 (1967) 417.

Hughes D. Caspary E. A. Lymphocyte transformation in vitro measured by tritiated thymidine uptake. Int. Arch. Allergy 37 (1970) 506.

Shenton B. K. Field E. J. The macrophage electrophoretic mobility test (MEM). Some technical considerations. J. immunol. Methods 7 (1975) 149.

Field E. J. Caspary E. A. Lymphocyte sensitisation: An in vitro test for cancer? Lancet 2 (1970) 1337.

Caspary E. A. Field E. J. Lymphocyte sensitisation in sarcoidosis. Brit. med. J. 2 (1971) 143.

Caspary E. A. Feinmann E. L. Field E. J. Lymphocyte sensitisation in asthma with special reference to nature and identity of intrinsic form. Brit. med. J. 1 (1973) 15.

Dunstone G. H. Knaggs T. W. L. Familial cancer of the colon and rectum. J. med. Genet. 9 (1972) 451.

Field E. J. Caspary E. A. Lymphocyte sensitisation in advanced malignant disease: A study of serum lymphocyte depressive factor. Brit. J. Cancer 26 (1972) 164.

Field E. J. Bates D. Shaw D. A. Griffin S. G. Shenton B. K. Smith J. K. Lymphocyte sensitisation in myasthenia gravis: Function of the adult thymus gland. Lancet 2 (1973) 675.

Field E. J. Shenton B. K. Assay of thymosin in blood. Lancet 1 (1975) 49.

Meyer-Rienecker H. Ernst K. Gundlach J. Shenton B. K. Field E. J. Prognosis after thymectomy for myasthenia gravis: A laboratory test. IRCS 3 (1975) 105.

Dickinson J. P. Caspary E. A. Field E. J. Localisation of tumour specific antigen on external surface of plasma membrane. Nature New Biol. 239 (1972) 181.

Caspary E. A. Field E. J. Specific lymphocyte sensitisation in cancer: Is there a common antigen in human malignant neoplasia? Brit. med. J. 2 (1971) 613.

Field E. J. Hughes D. Caspary E. A. Rapid development of a cancer-like antigen in normal tissue in vitro. Brit. J. Cancer 27 (1973) 427.

Pritchard J. A. V. Moore J. L. Sutherland W. H. Joslin C. A. F. Macrophage electrophoretic mobility (MEM) test for malignant disease. Lancet 2 (1972) 627.

Pritchard J. A. V. Moore J. L. Sutherland W. H. Joslin C. A. F. Evaluation and development of the macrophage electrophoretic mobility (MEM) test for malignant disease. Brit. J. Cancer 27 (1973) 1.

Preece A. W. Light P. A. The macrophage electrophoretic mobility (MEM) test for malignant disease. Further clinical investigations and studies of macrophage slowing factors. Clin. exp. Immunol. 18 (1974) 543.

Meyer-Rienecker H. Jenssen H. L. Kohler H. Gunther J. Gundlach H. J. Zur Anwendung und Bedeutung des makrophagen-elektrophorese-mobilitäts-(MEM) Testes bei neurologischen Erkrankungen. Klin. Wschr. 52 (1974) 288.

Meyer-Rienecker H. Jenssen H. L. Kohler H. Gunther J. K. Makrophagen-Elektrophorese-mobilitäts-Test (MEM) bei malignen Neoplasmen des Zentralnervensystems. Dtsch. Gesundh. Wes. 29 (1974) 844.

Goldstone A. H. Kerr L. Irvine W. J. The macrophage electrophoretic migration test in cancer. Clin. exp. Immunol. 14 (1973) 469.

Porzsolt F. Tautz C. H. Ax W. Electrophoretic mobility test: I. Modifications to simplify the detection of malignant diseases in man. Behring Inst. Mitt. 57 (1975) 128.

Porzsolt F. Muhlberger G. Ax W. Electrophoretic mobility test (EMT): II. Is there a correlation between the clinical diagnosis and immunologic test for precancerous diseases? Behring Inst. Mitt. 57 (1975) 137.

Field E. J. Caspary E. A. “Spontaneous” lymphocyte reactivity in the presence of virus infection. Lancet 1 (1972) 963.

Field E. J. Shenton B. K. Macrophage electrophoretic mobility (MEM) test for lymphocyte sensitisation: Importance of macrophages from healthy animals. IRCS 3 (1975) 154.

Field E. J. Shenton B. K. The macrophage electrophoretic mobility test (MEM): A consideration of the practical difficulties and application of the method. IRCS 3 (1975) 583.

Shenton B. K. Hughes D. Field E. J. Macrophage electrophoretic migration (MEM) test for lymphocyte sensitisation: Some practical experiences in macrophage selection. Brit. J. Cancer 28 Suppl. I, (1973) 215.

Field E. J. Caspary E. A. Lymphocyte sensitisation in advanced malignant disease: A study of serum lymphocyte depressive factor. Brit. J. Cancer 26 (1972) 164.

Hamlin I. M. E. Possible host resistance in carcinoma of the breast: A histological study. Brit. J. Cancer 22 (1968) 383.

Black M. M. Opler S. R. Speer F. D. Structural representations of tumour-host relationships in gastric carcinoma. Surg. Gynec. Obstet. 102 (1956) 599.

Martin R. F. Beckwith J. B. Lymphoid infiltrates in neuroblastomas: Their occurrence and prognostic significance. J. pediat. Surg. 3 (1968) 161.

Field E. J. Caspary E. A. Shepherd R. T. H. Immunodiagnosis of cancer. Brit. med. J. 1 (1971 641.